v3.25.4
Collaborative Arrangements - Ridgeback Biotherapeutics LP (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 65,011 $ 64,168 $ 60,115
Cost of sales 16,382 15,193 16,126
Selling, general and administrative 10,733 10,816 10,504
Research and development 15,789 17,938 30,531
Other current assest 43,516 38,782  
Accrued and other current liabilities 14,468 15,694  
Ridgeback Biotherapeutics LP | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cost of sales 235 554 852
Selling, general and administrative 54 57 97
Research and development 31 13 60
Other current assest 27 0  
Accrued and other current liabilities 11 68  
Ridgeback Biotherapeutics LP | Lagevrio | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 380 $ 964 $ 1,428